-
RIL, Aurobindo Pharma, Britannia Industries to be watched
Zydus Cadila has received an order to supply one crore doses of ZyCoV-D, to the Government of India at Rs. 265 per dose.
-
Infosys, Wipro, Aurobindo Pharma in spotlight
Here is the list of top stocks that could be in focus on August 27, Friday.
-
Aurobindo Pharma rallies after calling off proposed deal to buy 51% stake in Cronus Pharma
The company had entered into binding agreements with Cronus for acquisition of 51% ownership by subscribing to 95,059,963 equity shares
-
HDFC Mutual Fund cuts stake in Aurobindo Pharma
Aurobindo Pharma on August 12 posted a 1.68% decline in its consolidated net profit to Rs 769.97 crore for the quarter ended on June 30.
-
Stocks to watch: MTNL, SJVN, NTPC, Coal India, Unichem Labs
Ugro Capital is nearly trebling its headcount to 1,000 to drive both footprint and balance-sheet expansion by March
-
Aurobindo Pharma Q4 net profit at Rs 801.18 crore
Aurobindo Pharma's consolidated revenue from operations stood at Rs 6,001.50 crore for the quarter under consideration. It was Rs 6,158.43 crore a yea
-
Neelkanth Mishra suggests these changes for your portfolio
Credit Suisse removed Tata Steel from its 30-stock portfolio and added Hindalco citing an aluminium-to-steel price ratio near a two-decade low, an inv
-
Best pharma stocks to buy in 2021
Aurobindo Pharma, IPCA Labs, Cadila Healthcare, Cipla, Sun Pharma, Lupin, Dr. Reddy’s Labs & Biocon are best pharma stocks to buy in 2021
-
Aurobindo Pharma shares extend gain for fifth straight session
Nifty Pharma index of which Aurobindo Pharma Ltd is a constituent, has gained around 13.41% in last one month and is currently quoting at 13426.9, up
-
Nifty Pharma at record highs, in for a long haul
The Nifty Pharma index closed at record highs of 13,426 gaining 1.29% on Tuesday, while the benchmark Nifty index ended below 14,300-mark at 14,296 af
